The CRISPR gene-editing technology should be used to eliminate hereditary diseases in human embryos. While it offers the potential to eradicate devastating conditions, it also raises ethical concerns about genetic enhancement and unintended consequences. Do the benefits outweigh the risks of altering the human germline?